Real world clinical study of IPRM in the treatment of Acne Mastitis with retention of toxins syndrome type

注册号:

Registration number:

ITMCTR2000003613

最近更新日期:

Date of Last Refreshed on:

2020-08-21

注册时间:

Date of Registration:

2020-08-21

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

切开整复法治疗粉刺性乳痈“余毒未清证” 的真实世界临床研究

Public title:

Real world clinical study of IPRM in the treatment of Acne Mastitis with retention of toxins syndrome type

注册题目简写:

English Acronym:

研究课题的正式科学名称:

切开整复法治疗粉刺性乳痈“余毒未清证” 的真实世界临床研究

Scientific title:

Real world clinical study of IPRM in the treatment of Acne Mastitis with retention of toxins syndrome type

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000036132 ; ChiMCTR2000003613

申请注册联系人:

叶媚娜

研究负责人:

叶媚娜

Applicant:

Ye Meina

Study leader:

Ye Meina

申请注册联系人电话:

Applicant telephone:

+86 18930282548

研究负责人电话:

Study leader's telephone:

+86 18930282548

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yemeina2002@126.com

研究负责人电子邮件:

Study leader's E-mail:

yemeina2002@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

上海市徐汇区宛平南路725号

研究负责人通讯地址:

上海市徐汇区宛平南路725号

Applicant address:

725 Wanping Road South, Xuhui District, Shanghai, China

Study leader's address:

725 Wanping Road South, Xuhui District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海中医药大学附属龙华医院

Applicant's institution:

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2020

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

上海中医药大学附属龙华医院医学伦理委员会

Name of the ethic committee:

Institutional Review Board Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020/8/14 0:00:00

伦理委员会联系人:

刘蕾

Contact Name of the ethic committee:

LeiLiu

伦理委员会联系地址:

上海市徐汇区宛平南路725号

Contact Address of the ethic committee:

725 Wanping South Road, Xuhui District, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 021-64385700-1318

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海中医药大学附属龙华医院

Primary sponsor:

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

上海市徐汇区宛平南路725号

Primary sponsor's address:

725 Wanping Road South, Xuhui District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属龙华医院

具体地址:

徐汇区宛平南路725号

Institution
hospital:

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Address:

725 Wanping Road South, Xuhui District

经费或物资来源:

上海申康医院发展中心

Source(s) of funding:

Shanghai Shenkang Hospital Development Center

研究疾病:

粉刺性乳痈

研究疾病代码:

Target disease:

Acne Mastitis

Target disease code:

研究类型:

Study type:

观察性研究

Observational study

研究设计:

Study design:

单臂

Single arm

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

本研究通过真实世界临床研究从复发率、疮面愈合率、疮面愈合时间、乳头外形评分以及粉刺性乳痈患者报告结局量表客观评价切开整复法治疗粉刺性乳痈“余毒未清证”的临床疗效。

Objectives of Study:

This study objectively evaluated the clinical efficacy of incise and plastic repair method(IPRM) in the treatment of Acne Mastitis with retention of toxins syndrome type from the recurrence rate, wound surface healing rate, wound surface healing time, nipple shape score and acne mastitis patient report outcome scale through real-world clinical research.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1) 符合粉刺性乳痈(非哺乳期乳腺炎)诊断标准; 2) 符合余毒未清证诊断标准; 3) 年龄为20~55周岁的女性; 4) 病变范围累及乳头乳晕部且≤1个象限。 5) 签署知情同意书。

Inclusion criteria

1) Accord with the diagnosis standard of Acne Mastitis (non-lactation mastitis). 2) According to the diagnostic criteria of retention of toxins syndrome type. 3) Female aged from 20 to 55 years old. 4) The lesion area involved nipple and Areola and <= 1 quadrant of breast. 5) Sign an informed consent form.

排除标准:

1) 合并有心血管、脑血管、肝、肾和造血系统等严重原发性疾病,影响生存的严重疾病或精神病患者。 2) 合并严重感染,病情危重者。 3) 病变范围不累及乳头乳晕部或超过1个象限者。 4) 近1个月内参加其它临床试验的患者。 5) 有核磁共振检查禁忌症的患者。 6) 研究者认为不合适参加的患者。

Exclusion criteria:

1) Patients with serious primary diseases, such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, which affect their survival. 2) The patient with severe infection and serious condition. 3) The lesion does not involve the nipple and Areola or is more than 1 quadrant of breast. 4) Patients who participated in other clinical trials within 1 month. 5) Patients with MRI contraindications. 6) Patients who were considered unsuitable by the researchers.

研究实施时间:

Study execute time:

From 2020-10-01

To      2022-09-30

征募观察对象时间:

Recruiting time:

From 2020-10-01

To      2022-09-30

干预措施:

Interventions:

组别:

1

样本量:

60

Group:

1

Sample size:

干预措施:

外治法

干预措施代码:

Intervention:

external treatment of TCM

Intervention code:

组别:

1

样本量:

60

Group:

1

Sample size:

干预措施:

切开整复法手术

干预措施代码:

Intervention:

surgery of incise and plastic repair method

Intervention code:

组别:

1

样本量:

60

Group:

1

Sample size:

干预措施:

中药内服

干预措施代码:

Intervention:

herbal oral administration

Intervention code:

样本总量 Total sample size : 60

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属龙华医院

单位级别:

三级甲等

Institution/hospital:

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

乳头外形评分

指标类型:

主要指标

Outcome:

Nipple shape score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疮面愈合率

指标类型:

主要指标

Outcome:

Wound healing rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

复发率

指标类型:

主要指标

Outcome:

Recurrence rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疮面愈合时间

指标类型:

主要指标

Outcome:

Healing time of sore surface

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小
Min age years
最大
Max age years

Recruiting status:

Participant age:

性别:

Gender:

女性

Female

随机方法(请说明由何人用什么方法产生随机序列):

非随机

Randomization Procedure (please state who generates the random number sequence and by what method):

Nonrandomization

盲法:

N/A

Blinding:

N/A

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan临床试验公共管理平台, http://www.medresman.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan, http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集:CRF 数据管理:ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data acquisition:CRF Data management:ResMan

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above